EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions

Aarav Badani, Ahmad Ozair, Mustafa Khasraw, Graeme F Woodworth, Pallavi Tiwari, Manmeet S Ahluwalia, Alireza Mansouri

Journal of Neuro-Oncology · 2025

DOI: 10.1007/s11060-024-04881-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Aarav Badani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA. Hauptthemen laut MEDLINE: Glioblastoma, Immune Checkpoint Inhibitors, Brain Neoplasms, Immunotherapy. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaImmune Checkpoint InhibitorsBrain NeoplasmsImmunotherapyHumansTumor Microenvironment

Stichwörter der Autor:innen

Brain malignancyDurvalumabImmune exhaustionImmunotherapyIpilimumabNivolumabPembrolizumab

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
  • Department of Neuroscience, University of California, Berkeley, CA, USA.
  • Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, USA.
  • Brain Tumor Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • University of Maryland - Medicine Institute for Neuroscience Discovery (UM-MIND), Baltimore, MD, USA.

Förderung

  • BLRD VA
  • NCI NIH HHS

Zitieren

APA

Badani, A., Ozair, A., Khasraw, M., Woodworth, G. F., Tiwari, P., Ahluwalia, M. S., & Mansouri, A. (2025). Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04881-2

Vancouver

Badani A, Ozair A, Khasraw M, Woodworth GF, Tiwari P, Ahluwalia MS, et al. Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-024-04881-2

BibTeX
@article{Badani2025,
  author = {Badani, Aarav and Ozair, Ahmad and Khasraw, Mustafa and Woodworth, Graeme F and Tiwari, Pallavi and Ahluwalia, Manmeet S and Mansouri, Alireza},
  title = {Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions},
  journal = {Journal of Neuro-Oncology},
  year = {2025},
  doi = {10.1007/s11060-024-04881-2}
}
Kostenlos starten →